BEDROSIAN CAMILLE L (Chief Medical Officer) received a stock award from AMYLYX PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/9/2026ACC: 0001193125-26-098436
Officer· Chief Medical Officer
Since Mar 2026
+239.97K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
239.97K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+95.99K
Price / share
—
Trade value
—
% of position
56.7%
3/5/2026
169.29K→265.29K
Total
Net shares
+95.99K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | A · Award | +95.99K | — | — | 56.7% | 169.29K | 265.29K |
| Total | +95.99K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
143.99K shares
Shares
+143.99K
Strike price
14.10
Held after
143.99K
Exercisable
—
3/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock143.99K shares | 3/5/2026 | A · Award | +143.99K | 14.10 | — | 143.99K |